Alnylam Pharmaceuticals to Webcast Conference Call Discussing Fourth Quarter and 2012 Financial Results
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will report financial results for the fourth quarter and year ending December 31, 2012, on Thursday, February 7, 2013, after the U.S. financial markets close.